VC-resist glioblastoma cell state: vessel co-option as a key driver of chemoradiation resistance.

Autor: Pichol-Thievend C; Institut Curie, INSERM U1021, CNRS UMR3347, Tumor Microenvironment Lab, Paris-Saclay University, 91400, Orsay, France., Anezo O; Institut Curie, INSERM U1021, CNRS UMR3347, Tumor Microenvironment Lab, Paris-Saclay University, 91400, Orsay, France., Pettiwala AM; Institut Curie, INSERM U1021, CNRS UMR3347, Tumor Microenvironment Lab, Paris-Saclay University, 91400, Orsay, France.; Institut Curie, PSL University, 75005, Paris, France., Bourmeau G; Institut Curie, INSERM U1021, CNRS UMR3347, Tumor Microenvironment Lab, Paris-Saclay University, 91400, Orsay, France., Montagne R; Institut Curie, PSL University, 75005, Paris, France.; INSERM U900, 75005, Paris, France.; MINES ParisTeach, CBIO-Centre for Computational Biology, PSL Research University, 75006, Paris, France., Lyne AM; Institut Curie, PSL University, 75005, Paris, France.; INSERM U900, 75005, Paris, France.; MINES ParisTeach, CBIO-Centre for Computational Biology, PSL Research University, 75006, Paris, France., Guichet PO; Université de Poitiers, CHU Poitiers, ProDiCeT, F-86000, Poitiers, France.; CHU Poitiers, Laboratoire de Cancérologie Biologique, F-86000, Poitiers, France., Deshors P; Institut Curie, INSERM U1021, CNRS UMR3347, Tumor Microenvironment Lab, Paris-Saclay University, 91400, Orsay, France., Ballestín A; Institut Curie, INSERM U1021, CNRS UMR3347, Tumor Microenvironment Lab, Paris-Saclay University, 91400, Orsay, France., Blanchard B; Institut Curie, INSERM U1021, CNRS UMR3347, Tumor Microenvironment Lab, Paris-Saclay University, 91400, Orsay, France., Reveilles J; Institut Curie, INSERM U1021, CNRS UMR3347, Tumor Microenvironment Lab, Paris-Saclay University, 91400, Orsay, France., Ravi VM; Department of Neurosurgery, Medical Center - University of Freiburg, Freiburg, Germany., Joseph K; Department of Neurosurgery, Medical Center - University of Freiburg, Freiburg, Germany., Heiland DH; Department of Neurosurgery, Medical Center - University of Freiburg, Freiburg, Germany., Julien B; Institut Curie, INSERM U1021, CNRS UMR3347, Tumor Microenvironment Lab, Paris-Saclay University, 91400, Orsay, France., Leboucher S; Histology Facility, Institut Curie, 91400, Orsay, France., Besse L; Institut Curie, PSL University, Université Paris-Saclay, CNRS UMS2016, INSERM US43, Multimodal Imaging Center, 91400, Orsay, France., Legoix P; Institut Curie, PSL University, ICGex Next-Generation Sequencing Platform, 75005, Paris, France., Dingli F; Institut Curie, PSL University, CurieCoreTech Spectrométrie de Masse Protéomique, 75005, Paris, France., Liva S; Institut Curie, PSL University, 75005, Paris, France.; INSERM U900, 75005, Paris, France.; MINES ParisTeach, CBIO-Centre for Computational Biology, PSL Research University, 75006, Paris, France., Loew D; Institut Curie, PSL University, CurieCoreTech Spectrométrie de Masse Protéomique, 75005, Paris, France., Giani E; Department of Biomedical Sciences, Humanitas University, 20072, Pieve Emanuele, Italy., Ribecco V; Institut Curie, INSERM U1021, CNRS UMR3347, Tumor Microenvironment Lab, Paris-Saclay University, 91400, Orsay, France., Furumaya C; Institut Curie, INSERM U1021, CNRS UMR3347, Tumor Microenvironment Lab, Paris-Saclay University, 91400, Orsay, France., Marcos-Kovandzic L; Institut Curie, INSERM U1021, CNRS UMR3347, Tumor Microenvironment Lab, Paris-Saclay University, 91400, Orsay, France., Masliantsev K; Université de Poitiers, CHU Poitiers, ProDiCeT, F-86000, Poitiers, France.; CHU Poitiers, Laboratoire de Cancérologie Biologique, F-86000, Poitiers, France., Daubon T; Université Bordeaux, CNRS, IBGC, UMR5095, Bordeaux, France., Wang L; Department of Computational and Quantitative Medicine, Hematologic Malignancies Research Institute and Beckman Research Institute, City of Hope, Duarte, CA, USA., Diaz AA; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Schnell O; Department of Neurosurgery, Medical Center - University of Freiburg, Freiburg, Germany., Beck J; Department of Neurosurgery, Medical Center - University of Freiburg, Freiburg, Germany., Servant N; Institut Curie, PSL University, 75005, Paris, France.; INSERM U900, 75005, Paris, France.; MINES ParisTeach, CBIO-Centre for Computational Biology, PSL Research University, 75006, Paris, France., Karayan-Tapon L; Université de Poitiers, CHU Poitiers, ProDiCeT, F-86000, Poitiers, France.; CHU Poitiers, Laboratoire de Cancérologie Biologique, F-86000, Poitiers, France., Cavalli FMG; Institut Curie, PSL University, 75005, Paris, France.; INSERM U900, 75005, Paris, France.; MINES ParisTeach, CBIO-Centre for Computational Biology, PSL Research University, 75006, Paris, France., Seano G; Institut Curie, INSERM U1021, CNRS UMR3347, Tumor Microenvironment Lab, Paris-Saclay University, 91400, Orsay, France. giorgio.seano@curie.fr.

Publikováno v: Nature communications [Nat Commun] 2024 Apr 29; Vol. 15 (1), pp. 3602. Date of Electronic Publication: 2024 Apr 29.

The naturally occurring GIP(1-30)NH2 is a GIP receptor agonist in humans

Autor: Liva S L Krogh, Kristine Henriksen, Signe Stensen, Kirsa Skov-Jeppesen, Natasha C Bergmann, Joachim Størling, Mette M Rosenkilde, Bolette Hartmann, Jens J Holst, Lærke S Gasbjerg, Filip K Knop

Publikováno v: European Journal of Endocrinology. 188

ObjectiveThe gut hormone glucose-dependent insulinotropic polypeptide (GIP) is an important regulator of glucose and bone metabolism. In rodents, the naturally occurring GIP variant, GIP(1-30)NH2, has shown similar effects as full-length GIP (GIP(1-4

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a404840649d866f6f9723e84652db3bc
https://doi.org/10.1093/ejendo/lvac015

Contributo allo studio della responsabilità in duplum nel deposito

Autor: Liva, S.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3662::bcbcfab97dd53699505af25925143cf2
https://hdl.handle.net/11379/569299

Prevalence of Sex-Specific Cardiovascular Disease Risk Factors, Medical Risk, and Engagement in Health-Promoting Behaviours in Premenopausal Females.

Autor: Szakun N; School of Human Kinetics, Trinity Western University, Langley, British Columbia, Canada., Liva S; School of Nursing, Trinity Western University, Langley, British Columbia, Canada., Bodner ME; School of Human Kinetics, Trinity Western University, Langley, British Columbia, Canada., Wolff A; School of Nursing, Trinity Western University, Langley, British Columbia, Canada., Kim MY; School of Nursing, Trinity Western University, Langley, British Columbia, Canada., Cote AT; School of Human Kinetics, Trinity Western University, Langley, British Columbia, Canada.; Faculty of Medicine, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.

Publikováno v: CJC open [CJC Open] 2023 Nov 07; Vol. 6 (2Part B), pp. 301-313. Date of Electronic Publication: 2023 Nov 07 (Print Publication: 2024).

Un'iscrizione di Alba Fucens: organi municipali e rapporti con Roma nel I secolo d.C

Autor: Liva, S.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3662::9457eba5feba22cd11d8e4a06124af27
http://hdl.handle.net/11379/563602